Prednisolone phosphate
Showing 51 - 75 of 1,846
Postoperative Pain Trial in Shibin Al Kawm (Methylprednisolone Injection, Bupivacaine Hcl 0.5% Inj_#2, normal saline)
Recruiting
- Postoperative Pain
- Methylprednisolone Injection
- +2 more
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University hospitals
Jun 7, 2023
Fractures, Bone, Fractures, Closed, Radius Fracture Distal Trial in Indianapolis (Dexamethasone, Methylprednisolone, Standard of
Active, not recruiting
- Fractures, Bone
- +2 more
- Dexamethasone
- +2 more
-
Indianapolis, IndianaIndiana Hand to Shoulder Center
Dec 14, 2022
Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))
Recruiting
- Multiple Sclerosis
- Methylprednisolone
- +3 more
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 5, 2023
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Caudal Block Trial (caudal block using dexamethasone, caudal block using methylprednisolone)
Not yet recruiting
- Caudal Block
- caudal block using dexamethasone
- caudal block using methylprednisolone
- (no location specified)
Jan 28, 2023
Shoulder Pain Trial in Alexandria (Platelet rich plasma, Methylprednisolone)
Active, not recruiting
- Shoulder Pain
- Platelet rich plasma
- Methylprednisolone
-
Alexandria, EgyptFacility of medicine
Sep 14, 2022
Chronic Allergic Conjunctivitis Trial in Andover (Prednisolone Sodium Phosphate Ophthalmic Solution 1%, Tears Naturale II
Completed
- Chronic Allergic Conjunctivitis
- Prednisolone Sodium Phosphate Ophthalmic Solution 1%
- Tears Naturale II Ophthalmic Solution
-
Andover, MassachusettsAndover Eye Associates
Jun 18, 2019
Plantar Fascitis Trial in Minya (platelet rich plasma, MethylPREDNISolone 40 MG)
Completed
- Plantar Fascitis
- platelet rich plasma
- MethylPREDNISolone 40 MG
-
Minya, EgyptMinya university
Jul 2, 2022
Cataract Diabetic, Macula Edema Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)
Not yet recruiting
- Cataract Diabetic
- Macula Edema
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
- (no location specified)
Jul 15, 2021
Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Methylprednisolone,
Recruiting
- Multiple Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Normal Physiology Trial run by the NIAID (Methylprednisolone sodium succinate(Solu-Medrol), Topical methylprednisolone (Advantan
Completed
- Normal Physiology
- Methylprednisolone sodium succinate(Solu-Medrol)
- Topical methylprednisolone (Advantan emulsion 0 /1%)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 18, 2022
Sarcoidosis Trial in Chandigarh (Low dose prednisolone, Medium dose prednisolone)
Completed
- Sarcoidosis
- Low dose prednisolone
- Medium dose prednisolone
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jan 7, 2023
Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,
Recruiting
- Hormone Sensitive Metastatic Prostate Cancer
- +3 more
- Docetaxel
- +2 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022
Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)
Not yet recruiting
- Vitreoretinopathy
- +8 more
- Dextenza 0.4Mg Ophthalmic Insert
- Pred Forte
-
Durham, North CarolinaDuke Eye Center
Nov 10, 2022
Sudden Sensorineural Hearing Loss Trial (Statin, methylprednisolone, dexamethasone)
Not yet recruiting
- Sudden Sensorineural Hearing Loss
- Statin
- +3 more
- (no location specified)
Feb 2, 2023
Posner Schlossman Syndrome Trial in Beijing (FK-506 (Drug), Prednisolone Acetate 1% Oph Susp)
Recruiting
- Posner Schlossman Syndrome
- FK-506 (Drug)
- Prednisolone Acetate 1% Oph Susp
-
Beijing, Beijing, ChinaPeking University Third Hosipital
Aug 13, 2021
Autoimmune Hepatitis, Primary Biliary Cirrhosis Trial in Chengdu (Methylprednisolone and Mycophenolate mofetil,
Recruiting
- Autoimmune Hepatitis
- Primary Biliary Cirrhosis
- Methylprednisolone and Mycophenolate mofetil
- Methylprednisolone and azathioprine
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan Univerisity
Jun 18, 2021
Inflammatory Response, Weakness, Muscle Trial (Methylprednisolone, NaCl 0.9%)
Recruiting
- Inflammatory Response
- Weakness, Muscle
- Methylprednisolone
- NaCl 0.9%
-
Genk, BelgiumZiekenhuis Oost-Limburg
Jan 25, 2023
Rhinitis, Allergic, Seasonal, Hay Fever, Pollen Allergy Trial in Lund (MethylPREDNISolone 40 Mg/mL Injectable Suspension, NaCl 9
Active, not recruiting
- Rhinitis, Allergic, Seasonal
- +3 more
- MethylPREDNISolone 40 Mg/mL Injectable Suspension
- NaCl 9 MG/ML Injectable Solution
-
Lund, Skane, SwedenDepartment of Lung-and Allergy Research
Jun 22, 2022
Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)
Completed
- Graves Ophthalmopathy
-
Sofia, BulgariaUniversity Hospital of Endocrinology
Mar 29, 2023
Knee Arthritis Trial in Atlanta, Tucker (Methylprednisolone, Standard of Care)
Not yet recruiting
- Knee Arthritis
- Methylprednisolone
- Standard of Care
-
Atlanta, Georgia
- +1 more
May 5, 2023